12‑Panel Multi-Drug Rapid Urine Test Cup (Includes Fentanyl 1 ng/mL) — FDA 510(k) Cleared — 100/Case

The 12‑Panel Rapid Urine Test Cup (incl. Fentanyl) provides comprehensive screening for 12 substances, now including an ultra‑sensitive fentanyl (FYL) panel at 1 ng/mL. Each kit contains 100 individually sealed cups with integrated 3 mm collection chambers, designed for professional laboratory and clinical settings. Built‑in reagents produce clear, visible results within minutes, eliminating the need for separate testing equipment. The standardized 3 mm depth ensures consistent sample collection and accurate detection across all tested compounds. Ideal for workplace compliance programs, medical facilities, and substance‑use monitoring, this test cup combines ease of use with dependable performance for high‑volume screening.

FDA 510(k) cleared panels; distributed by an FDA‑registered medical distributor. For professional in vitro diagnostic screening use only. All positive results are presumptive and should be confirmed using a laboratory method such as GC/MS or LC‑MS/MS. CLIA‑waived status, where applicable, varies by configuration; consult product labeling. Store at room temperature per packaging instructions.

What’s Included:

• 100 x Multi‑Drug Rapid Urine Test Cups (individually pouched)
• Instructions for use (IFU)

How to Use:

• Collect urine directly into the cup to the indicated fill line.
• Secure the lid and activate per IFU.
• Read results within the specified time window; do not interpret after the maximum read time.
• Video instructions: https://www.youtube.com/watch?v=4zRgq1UGkZI

Key Features:

• FDA 510(k) cleared panels; distributed by an FDA‑registered medical distributor
• Includes Fentanyl (FYL) panel at 1 ng/mL sensitivity
• Integrated cup with built‑in reagents — no separate analyzer required
• Standardized 3 mm collection chamber for consistent sampling
• Clear, visible results within minutes
• 100 individually sealed cups per box — ideal for high‑volume screening
• For professional use in clinical, laboratory, and workplace compliance programs
• Presumptive screening only; confirm positives by GC/MS or LC‑MS/MS

Drugs Detected:

• AMP at 500 ng/mL (Amphetamines)
• BAR at 300 ng/mL (Barbiturates)
• BZO at 300 ng/mL (Benzodiazepines)
• BUP at 10 ng/mL (Buprenorphine)
• COC at 150 ng/mL (Cocaine)
• THC at 50 ng/mL (Marijuana)
• MTD at 300 ng/mL (Methadone)
• MET at 500 ng/mL (Methamphetamine)
• MDMA at 500 ng/mL (Ecstasy)
• MOP at 300 ng/mL (Morphine/OPI 300)
• OXY at 100 ng/mL (Oxycodone)
• FYL at 1 ng/mL (Fentanyl)